Investor Presentation • Aug 20, 2023
Investor Presentation
Open in ViewerOpens in native device viewer

August 2023
This presentation was prepared by Turpaz Industries Ltd. (the "Company") for the sole purpose of conveying information regarding the Company and its subsidiaries (together with the Company "Turpaz Group"). This presentation does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities of the Company and is intended to provide information only. This presentation is not intended to replace the need to review the Company's full reports to the Securities Authority and the Tel Aviv Stock Exchange Ltd. including, inter alia, the Company's periodic and immediate reports (hereinafter: "Company Reports") prior to making a decision regarding investment in the Company's securities.
In addition, this presentation cannot replace investment consulting by a lawfully licensed investment consultant.
This presentation includes statements data, forecasts, goals and Company plans that are "forward-looking statements", as defined in the Securities Law - 1968, whose occurrence is not certain, and which are not solely in the Company's control.
These forward-looking statements are included, inter alia, in discussions of strategy, objectives, goals, plans, events, future intentions or other information relating to future events or issues whose occurrence is not certain.
By their nature, forward-looking statements involve risk and uncertainty. Whether the forward-looking information occurs or not is affected, inter alia, by risk factors characteristic to the Company's operations and developments in the general environment and external factors which impact the Turpaz Group and its area of activities.
Subject to the requirements of applicable law, the Company does not intend to update any industry information or forward-looking statements appearing in this presentation and is not required to publish any additional presentations for its shareholders in future.

| Sales \$ 61.5M + 6.6% Sales growth (2.7%) Organic |
Gross Profit \$ 23.0M + 3.0% growth |
Adjusted EBITDA \$ 12.6M (5.2%) |
|
|---|---|---|---|
| Sales were impacted by continued customer destocking, driven by global interest rate increases and market economic uncertainties |
Gross profit increased mainly due to the increase in sales. Profitability declined primarily due to an organic sales decrease compounded by fixed expenses, rising energy prices, and increased payroll costs |
The change in adjusted EBITDA stems mainly from the organic decline in sales |
| Sales \$ 30.6M + 1.1% Sales growth (6.6%) Organic |
Gross Profit \$ 11.2M (3.8%) |
Adjusted EBITDA \$ 6.0M (13.8%) |
|
|---|---|---|---|
| Sales were impacted by continued customer destocking, driven by global interest rate increases and market economic uncertainties |
Profitability declined primarily due to an organic sales decrease compounded by fixed expenses, rising energy prices, and increased payroll costs |
The change in adjusted EBITDA stems mainly from the organic decline in sales |


(**)Adj. EBITDA - earnings before interest, taxes, depreciation, and amortization neutralization of one-time expenses of acquisitions and structural change.
6


(*) based on the company's internal reporting
(**)Adj. EBITDA - earnings before interest, taxes, depreciation, and amortization neutralization of one-time expenses of acquisitions and structural change.


| Net Sales | Operating Profit* | ||||
|---|---|---|---|---|---|
| In K US \$ / % | H1 2022 | H1 2023 | H1 2022 | H1 2023 | |
| Fragrance | 13,066 | 16,107 | 3,936 30.1% |
3,693 22.9% |
|
| Taste | 29,420 | 31,807 | 4,400 15.0% |
4,275 13.4% |
|
| Specialty Fine Ingredients |
15,224 | 13,712 | 4,208 27.6% |
3,011 22.0% |
*Operating profit was impacted by organic sales decrease from customer destocking, alongside fixed expenses, rising energy prices, and increased payroll costs.
| In K US \$ / % | Q2 2022 | Q2 2023 |
|---|---|---|
| Sales | 30,305 | 30,626 |
| Gross Profit | 11,660 38.5% |
11,215 36.6% |
| Operating Profit | 4,954 16.3% |
3,680 12.0% |
| Adjusted EBITDA | 6,990 23.1% |
6,026 19.7% |

| In K US \$ / % | Q2 2023 Q2 2022 |
|
|---|---|---|
| Sales | +15.1% 7,074 8,139 |
|
| Operating profit | 2,143 2,111 30.3% 25.9% |
|
| Organic | (5.6%) | |
| Acquisitions | Klabin | |
| Highlights | The increase in sales stems from the acquisition of Klabin in the fourth quarter of 2022. Organic decrease arises from an increase in orders placed in the first quarter of 2023, which experienced an organic growth of 15.0%, impacting the second quarter. Operating profit was influenced by an operational streamlining plan in USA, involving non-recurring expenses due to the closure of Turpaz USA site and relocating of manufacturing, development, and sales operations to Klabin's site. |

12
| In K US \$ / % | Q2 2023 Q2 2022 |
|
|---|---|---|
| Sales | (3.5%) 16,222 15,662 |
|
| Operating profit | 2,657 1,415 16.4% 9.0% |
|
| Organic | (9.4%) | |
| Acquisitions | Aromatique Food |
|
| Highlights | Sales decrease is mainly attributed to SDA, as intensified market competition and entry of new players into the market prompted the company to reduce sales to low-profitability customers, coupled with destocking among customers. |
| In K US \$ / % | Q2 2022 | Q2 2023 | ||
|---|---|---|---|---|
| Sales | (1.4%) 7,009 |
6,911 | ||
| Operating profit | 2,010 28.7% |
1,675 24.2% |
||
| Organic | 0.1% | |||
| Highlights | Sales mainly affected by customer destocking, and exchange rate impact. The change in profitability was driven by higher |
|||
| raw materials prices, coupled with fixed operating costs. |

| K US \$ | 2022 | Q2 2022 | Q2 2023 | H1 2022 | H1 2023 |
|---|---|---|---|---|---|
| Revenues | 118,556 | 30,305 | 30,626 | 57,710 | 61,540 |
| Gross Profit | 47,659 | 11,660 | 11,215 | 22,364 | 23,034 |
| Gross Profit % | 40.2% | 38.5% | 36.6% | 38.8% | 37.4% |
| R&D Expenses | 3,607 | 717 | 1,203 | 1,502 | 2,297 |
| Sales & Marketing Expenses | 10,016 | 2,171 | 2,573 | 4,514 | 5,099 |
| Management & General Expenses | 15,055 | 3,837 | 3,631 | 6,864 | 7,494 |
| Other Expenses (Income) | (8,349) | (19) | 128 | (27) | 304 |
| Operating Profit | 27,330 | 4,954 | 3,680 | 9,511 | 7,840 |
| Operating Profit % | 23.1% | 16.3% | 12.0% | 16.5% | 12.7% |
| Adj. Operating profit (*) | 19,153 | 5,065 | 3,785 | 9,727 | 8,117 |
| Net Profit | 21,331 | 4,239 | 2,512 | 8,199 | 5,519 |
| EBITDA | 35,039 | 6,879 | 5,921 | 13,092 | 12,343 |
| Adjusted EBITDA | 26,862 | 6,990 | 6,026 | 13,308 | 12,620 |
| Adjusted EBITDA % | 22.7% | 23.1% | 19.7% | 23.1% | 20.5% |
| Cash flow from operation | 31,938 | (4,259) | 4,953 | 1,109 | 218 |
* Adjusted to reflect operating profit without non-recurring expenses or income.
| K US \$ | 31/12/2022 | 30/6/2022 | 30/6/2023 |
|---|---|---|---|
| Assets | |||
| Current Assets | 89,913 | 91,769 | 72,370 |
| Non-Current Assets | 124,267 | 95,954 | 132,232 |
| Total Assets | 214,180 | 187,723 | 204,602 |
| Liabilities & Equity | |||
| Current Liabilities | 46,674 | 35,437 | 33,202 |
| Non-Current Liabilities | 63,981 | 63,137 | 66,842 |
| Equity | 103,525 | 89,149 | 104,558 |
| Total Liabilities and Equity | 214,180 | 187,723 | 204,602 |
| Ratio | |||
| Working Capital to Sales | 26.1% | 24.6% | 32.5% |
| Cash and Cash Equivalent | 35,675 | 31,476 | 14,964 |
| Net Cash (Net Debts)(*) | 19,107 | 16,039 | 6,989 |
| Equity to total balance sheet | 48.3% | 47.5% | 51.1% |

Turpaz's strong equity structure, low leverage, cash flow from operations, funding availability and the strengthening of management and managerial infrastructures enable the implementation of the group's combined growth strategy.
(*) Debts = Short and long-term loans from banks and other.






Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.